Whalegun

Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
1,007 trades
$2.1B in total
Open-market sales
1,285 trades
$2.7B in total
Insiders filing
580 insiders
Last 7 days
Companies with several buyers
33
Last 7 days
Mereo BioPharma Group MREO
Trade type
CEO
Mereo BioPharma GroupMREO
Open-market sale24/09/12–24/09/1324/09/1688,657 sh2 trades$4.30avg.$381,285.29−9.9%
Chief Scientific Officer
Mereo BioPharma GroupMREO
Open-market sale24/09/12–24/09/1324/09/1616,149 sh2 trades$4.30avg.$69,451.78−17.0%
General Counsel
Mereo BioPharma GroupMREO
Open-market sale24/09/12–24/09/1324/09/1630,926 sh2 trades$4.30avg.$133,002.72−12.4%
CFO
Mereo BioPharma GroupMREO
Open-market sale24/09/12–24/09/1324/09/1628,286 sh2 trades$4.30avg.$121,648.92−24.1%
SEE REMARKS
Mereo BioPharma GroupMREO
Open-market sale24/09/12–24/09/1324/09/16148,110 sh4 trades$4.30avg.$636,973.7−74.6%
Deepika PakianathanDirector
Mereo BioPharma GroupMREO
Open-market sale24/08/2224/08/23105,244 sh$4.43$466,230.92−100.0%
CEO
Mereo BioPharma GroupMREO
Open-market sale24/06/25–24/06/2624/06/27132,985 sh2 trades$3.48avg.$463,032.75−15.8%
Chief Scientific Officer
Mereo BioPharma GroupMREO
Open-market sale24/06/25–24/06/2624/06/2724,224 sh2 trades$3.48avg.$84,344.16−33.2%
General Counsel
Mereo BioPharma GroupMREO
Open-market sale24/06/25–24/06/2624/06/2746,389 sh2 trades$3.48avg.$161,519.31−20.1%
CFO
Mereo BioPharma GroupMREO
Open-market sale24/06/25–24/06/2624/06/2742,429 sh2 trades$3.48avg.$147,731.31−42.4%
SEE REMARKS
Mereo BioPharma GroupMREO
Open-market sale24/06/25–24/06/2624/06/2733,102 sh2 trades$3.48avg.$115,255.98−48.9%
SEE REMARKS
Mereo BioPharma GroupMREO
Open-market sale24/05/2224/05/23100,432 sh2 trades$2.97avg.$297,787.58−75.5%